BPA call - nextgen rbis operations and maintenance (O & M)
Ended Awarded Last action
- Contract number
- 75F40124F19007
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,910,037
Award facts
- Contract value 95% obligated
-
- $3,910,037.11 Current, with exercised options
- $4,103,107.30 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Calverton, MD 20705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $68,433 | |
| Other Administrative Action | $0 | |
| Original award | $3,841,604 |
About this award
Booz Allen Hamilton Inc. received a Blanket Purchase Agreement (BPA) call award from the Food and Drug Administration on March 25, 2024, for NextGen Regulatory Business Information System (RBIS) Operations and Maintenance services. The contract carries a ceiling value of approximately $4.1 million with a firm fixed-price structure and is scheduled for completion by July 31, 2025. The work will be performed in Calverton, Maryland. This award represents a task order issued under Booz Allen Hamilton's existing Multiple Award Schedule vehicle with the General Services Administration, which provides the FDA and other federal agencies access to a broad range of professional services including IT infrastructure support, systems engineering, and technical consulting.
The FDA's RBIS platform supports the agency's regulatory submission and business information management operations. Booz Allen Hamilton, a large business prime contractor headquartered in McLean, Virginia, brings substantial experience supporting FDA modernization initiatives, including previous work on electronic submissions systems and regulatory science optimization. This contract carries no small business set-aside designation, reflecting Booz Allen Hamilton's status as a large business competitor in full and open competition. The award underscores the company's established role as a trusted partner for FDA's mission-critical IT operations and maintenance requirements.
Quick answers
Who was awarded contract 75F40124F19007?
75F40124F19007 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on March 25, 2024.
How much is contract 75F40124F19007 worth?
The government has obligated $3,910,037 on 75F40124F19007. Its potential value, with all options, is $4,103,107.
Is contract 75F40124F19007 an order under another contract?
Yes. 75F40124F19007 is a BPA call under GS35F386DA-75F40122A00013, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40124F19007 competed?
The extent of competition for 75F40124F19007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award